NO20020565D0 - Interleukin-5-hemmende 6-azauracilderivater - Google Patents

Interleukin-5-hemmende 6-azauracilderivater

Info

Publication number
NO20020565D0
NO20020565D0 NO20020565A NO20020565A NO20020565D0 NO 20020565 D0 NO20020565 D0 NO 20020565D0 NO 20020565 A NO20020565 A NO 20020565A NO 20020565 A NO20020565 A NO 20020565A NO 20020565 D0 NO20020565 D0 NO 20020565D0
Authority
NO
Norway
Prior art keywords
interleukin
inhibiting
azauracil derivatives
azauracil
derivatives
Prior art date
Application number
NO20020565A
Other languages
English (en)
Other versions
NO322386B1 (no
NO20020565L (no
Inventor
Jean Fernand Armand Lacrampe
Jerome Michel Claude Fortin
Eddy Jean Edgard Freyne
Frederik Dirk Deroose
Erwin Coesemans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20020565D0 publication Critical patent/NO20020565D0/no
Publication of NO20020565L publication Critical patent/NO20020565L/no
Publication of NO322386B1 publication Critical patent/NO322386B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
NO20020565A 1999-08-06 2002-02-05 Interleukin-5-hemmende 6-azauracilderivater, sammensetninger inneholdende disse og fremgangsmater for deres fremstilling. NO322386B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870170 1999-08-06
EP99126035 1999-12-27
PCT/EP2000/007358 WO2001010866A1 (en) 1999-08-06 2000-07-31 Interleukin-5 inhibiting 6-azauracil derivatives

Publications (3)

Publication Number Publication Date
NO20020565D0 true NO20020565D0 (no) 2002-02-05
NO20020565L NO20020565L (no) 2002-03-26
NO322386B1 NO322386B1 (no) 2006-09-25

Family

ID=26153219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020565A NO322386B1 (no) 1999-08-06 2002-02-05 Interleukin-5-hemmende 6-azauracilderivater, sammensetninger inneholdende disse og fremgangsmater for deres fremstilling.

Country Status (30)

Country Link
US (1) US6911444B2 (no)
EP (1) EP1206471B1 (no)
JP (1) JP2003506451A (no)
KR (1) KR100795484B1 (no)
CN (1) CN1188410C (no)
AR (1) AR025046A1 (no)
AT (1) ATE318811T1 (no)
AU (1) AU780047B2 (no)
BG (1) BG106367A (no)
BR (1) BR0013014A (no)
CA (1) CA2380759A1 (no)
CO (1) CO5050264A1 (no)
CZ (1) CZ2002356A3 (no)
DE (1) DE60026312T2 (no)
EA (1) EA004740B1 (no)
EE (1) EE200200057A (no)
ES (1) ES2260031T3 (no)
HK (1) HK1048634B (no)
HR (1) HRP20020096A2 (no)
HU (1) HUP0202692A3 (no)
IL (1) IL147976A0 (no)
MX (1) MXPA02001343A (no)
MY (1) MY133512A (no)
NO (1) NO322386B1 (no)
NZ (1) NZ516506A (no)
PL (1) PL353475A1 (no)
SK (1) SK1642002A3 (no)
TR (1) TR200200310T2 (no)
TW (1) TWI271404B (no)
WO (1) WO2001010866A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2003211385A1 (en) * 2002-02-28 2003-09-09 Takeda Chemical Industries, Ltd. Azole compounds
BRPI0511671A (pt) * 2004-05-29 2008-01-02 7Tm Pharma As tiazolacético substituìdo como ligantes de crth2
JP5552121B2 (ja) 2008-09-04 2014-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のインドリジン阻害剤
JP4743340B1 (ja) * 2009-10-28 2011-08-10 セントラル硝子株式会社 保護膜形成用薬液
WO2011068821A1 (en) 2009-12-04 2011-06-09 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
JP5619284B2 (ja) 2010-08-16 2014-11-05 ベーリンガーインゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害薬
JP5862669B2 (ja) 2010-08-26 2016-02-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン産生のオキサジアゾール阻害剤
CN103261193A (zh) 2010-09-23 2013-08-21 贝林格尔.英格海姆国际有限公司 抑制白三烯生成的*二唑抑制剂
US8580825B2 (en) 2010-09-23 2013-11-12 Boehringer Ingelheim International Gmbh Oxadiazole inhibitors of leukotriene production
WO2012058254A1 (en) 2010-10-29 2012-05-03 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
US8772304B2 (en) 2010-11-01 2014-07-08 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
WO2012082817A1 (en) 2010-12-16 2012-06-21 Boehringer Ingelheim International Gmbh Biarylamide inhibitors of leukotriene production
AR089853A1 (es) 2012-02-01 2014-09-24 Boehringer Ingelheim Int Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US42416A (en) * 1864-04-19 Improvement in harvesters
US10177A (en) * 1853-11-01 Improved pen and pencil case
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
EE200000016A (et) * 1997-07-10 2000-10-16 Janssen Pharmaceutica N.V. IL-5 inhibeerivad 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, retseptori markeerimismeetod ja organi visualiseerimismeetod
TR199903249T2 (xx) * 1997-07-10 2000-09-21 Janssen Pharmaceutica N.V. �l-5 inhibit�rleri olarak 6-Azaurasil t�revleri.
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives

Also Published As

Publication number Publication date
CN1368972A (zh) 2002-09-11
DE60026312D1 (de) 2006-04-27
BR0013014A (pt) 2002-04-16
HRP20020096A2 (en) 2005-10-31
EA004740B1 (ru) 2004-08-26
HUP0202692A3 (en) 2003-01-28
KR20020012317A (ko) 2002-02-15
MXPA02001343A (es) 2002-07-22
CA2380759A1 (en) 2001-02-15
BG106367A (bg) 2002-09-30
CO5050264A1 (es) 2001-06-27
US20030114453A1 (en) 2003-06-19
DE60026312T2 (de) 2006-12-21
CN1188410C (zh) 2005-02-09
WO2001010866A1 (en) 2001-02-15
PL353475A1 (en) 2003-11-17
EA200200232A1 (ru) 2002-08-29
SK1642002A3 (en) 2003-03-04
JP2003506451A (ja) 2003-02-18
AU780047B2 (en) 2005-02-24
MY133512A (en) 2007-11-30
HUP0202692A2 (hu) 2002-12-28
NO322386B1 (no) 2006-09-25
NZ516506A (en) 2004-02-27
NO20020565L (no) 2002-03-26
AU6160900A (en) 2001-03-05
EE200200057A (et) 2003-04-15
EP1206471B1 (en) 2006-03-01
TWI271404B (en) 2007-01-21
IL147976A0 (en) 2002-09-12
AR025046A1 (es) 2002-11-06
TR200200310T2 (tr) 2002-08-21
KR100795484B1 (ko) 2008-01-16
HK1048634B (zh) 2005-09-30
HK1048634A1 (en) 2003-04-11
US6911444B2 (en) 2005-06-28
ES2260031T3 (es) 2006-11-01
EP1206471A1 (en) 2002-05-22
CZ2002356A3 (cs) 2002-06-12
ATE318811T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
IS5381A (is) 4-fenyl-pyridin afleiður
NO20021077L (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
DE50010060D1 (de) Thiazolylamid-derivate
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
NO20021803L (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
NO20020565L (no) Interleukin-5-hemmende 6-azauracilderivater
ATE374747T1 (de) Monofluoralkylderivate
ATE273272T1 (de) Mevinolinderivate
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE293592T1 (de) Resorcinderivate
NO20022867D0 (no) Syklopentenon-derivater
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
TR200002831A3 (tr) Kinolin-4-Il türevleri I
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DE60001736T2 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
ATE269328T1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees